ライフサイエンスコーパス: MACS

1 MACS is associated with cardiovascular morbidity, frailt

2 MACS is diagnosed (based on an abnormal overnight dexame

3 MACS was localized to 6q21 between D6S266 (LOD > 3.0) an

4 Among 341 MACS Caucasian SCs with 6- to 12-month human immunodefic

5 Additionally, MACS processing was 4-6 times faster than FACS for singl

6 orticoid excretion from NFAT over MACS-1 and MACS-2 to CS, whereas androgen excretion decreased.

7 nd magnetic-activated cell sorting (FACS and MACS, respectively), to more specialized approaches base

8 .62]; aPRs for use of >=3 antihypertensives: MACS-2, 1.31 [CI, 1.02 to 1.68], and CS, 2.22 [CI, 1.62

9 idual data from Swedish (BAMSE), Australian (MACS), Dutch (PIAMA), Canadian (CAPPS and SAGE), and Ger

10 -2.7; p<0.001) and after HAART availability (MACS, adjusted-OR, 1.5; 95%CI 1.3-1.7; p<0.001; WIHS adj

11 is and management of patients with bilateral MACS is especially challenging.

12 yzed CCR2-V64I using subjects in the Chicago MACS.

13 report multiband observations of the cluster MACS J1149+2223 that have revealed (with high probabilit

14 dren enrolled in the Melbourne Atopy Cohort (MACS) Study, a high-risk birth cohort study.

15 In sum, combining MACS with immunochemical and transcriptomics approaches

16 A cardiometabolic risk condition, MACS predominantly affects women and warrants regular as

17 sampled directly from a suspension culture, MACS bypasses the need for sample preparation, and there

18 l Cushing syndrome [CS] features, definitive MACS [MACS-2]).

19 ommon in HIV-infected participants in either MACS or WIHS participants.

20 nally, we provide instructions for extending MACS using an external growth chamber (1 d) and for how

21 e- and magnetic-activated cell sorting (FACS/MACS).

22 Finally, MACS can be used to impart mechanical pressure for asses

23 of linked and neighboring polymorphisms for MACS and MLP should permit similar genetic studies in ot

24 d more likely to require insulin therapy for MACS-2 (aPR, 1.89 [CI, 1.01 to 3.52]) and CS (aPR, 3.06

25 ribe the two sources of line broadening from MACS, sample temperature gradient and anisotropic magnet

26 tudied 1123 men (589 HIV+ and 534 HIV-) from MACS (Multicenter AIDS Cohort Study), using the ZioXT am

27 ronegative (HEPS; n = 90) Caucasian men from MACS more frequently carried heterozygous G*2 (Delta32)

28 Furthermore, MACS facilitates the visualization of individual cytopla

29 4 kb of promoter from the human MARCKS gene (MACS), with an epitope tag sequence inserted at the carb

30 er 433 bp to the promoter of the human gene, MACS, which encodes the MLP homologue MARCKS.

31 ninfected individuals in both the pre-HAART (MACS only) and HAART eras; and adjusted Cox proportional

32 ident respiratory infections both pre-HAART (MACS, odds ratio [adjusted-OR], 2.4; 95% confidence inte

33 % had NFAT (n = 649; 64.1% women), 34.6% had MACS-1 (n = 451; 67.2% women), 10.7% had MACS-2 (n = 140

34 had MACS-1 (n = 451; 67.2% women), 10.7% had MACS-2 (n = 140; 73.6% women), and 5.0% had CS (n = 65;

35 We demonstrate with the high quality HR-MACS NMR spectra of micronematodes and tissue biopsy, an

36 igh-resolution magic-angle coil spinning (HR-MACS) resonator that improves the spectral resolution.

37 igh-resolution magic-angle coil spinning (HR-MACS), a simple conversion of a standard HR-MAS probe to

38 d prevalence ratios [aPRs] for hypertension: MACS-2, 1.15 [95% CI, 1.04 to 1.27], and CS, 1.37 [CI, 1

39 Importantly, MACS sorts resulted in only 7-9% cell loss compared to ~

40 ructive pulmonary disease was more common in MACS HIV-infected vs. HIV-uninfected participants pre-HA

41 Current gaps in MACS clinical practice include a lack of specific biomar

42 and severity of hypertension were higher in MACS-2 and CS than NFAT (adjusted prevalence ratios [aPR

43 V-negative individuals (8.7 years younger in MACS (P < 0.01) and 7.6 years younger in WIHS (P < 0.01)

44 death compared to those without infections (MACS adjusted-HR, 1.5; 95%CI, 1.3-1.7; p<0.001; WIHS adj

45 Results showed that initial MACS runs performed using manufacturer's recommended ant

46 automation software is provided to integrate MACS control with image acquisition.

47 ho were 18 years or older were enrolled into MACS.

48 Broadly consistent findings in the larger MACS Caucasian SCs and the smaller groups of MACS Africa

49 ing syndrome [CS] features, definitive MACS [MACS-2]).

50 mor [NFAT]; 50 to 138 nmol/L, possible MACS [MACS-1]; >138 nmol/L and absence of typical clinical Cus

51 ltitarget magnetic activated cell sorter (MT-MACS), which makes use of microfluidics technology to ac

52 We used the MT-MACS device to purify 2 types of target cells, which had

53 Similar to O-MACS and Gstm2 had zonally restricted expression pattern

54 , Capza1, Bin3, Tom1, Acl6, and similar to O-MACS.

55 ing substantial optimization, the ability of MACS to isolate increased cell numbers in less time than

56 a lack of specific biomarkers diagnostic of MACS-related health outcomes and a paucity of clinical t

57 MACS Caucasian SCs and the smaller groups of MACS African-American SCs and the DCG and SFMHS Caucasia

58 Management of MACS should be individualized based on patient character

59 The operation of MACS is described, and automation software is provided t

60 enocytes ex vivo depleted of CD25+ cells, or MACS-isolated CD4+ CD25+ Treg.

61 specific and expensive labels (e.g. FACS or MACS).

62 e in glucocorticoid excretion from NFAT over MACS-1 and MACS-2 to CS, whereas androgen excretion decr

63 Among HIV-positive MACS participants, the proportion of deaths unrelated to

64 nal tumor [NFAT]; 50 to 138 nmol/L, possible MACS [MACS-1]; >138 nmol/L and absence of typical clinic

65 -seq) to unambiguously characterize the post-MACS cell products.

66 When processing multiple samples, MACS was always faster overall due to its ability to run

67 m for microfluidics-assisted cell screening (MACS) that overcomes this trade-off by temporarily immob

68 Mild autonomous cortisol secretion (MACS) is regularly diagnosed, but its effect on cardiome

69 revalent mild autonomous cortisol secretion (MACS) without signs of Cushing syndrome.

70 antibody and Magnetic Activated Cell Sorter (MACS) technique, we successfully purified Thy-1 positive

71 ibrary using magnetic-assisted cell sorting (MACS) and flow cytometry.

72 A combination of magnetic cell sorting (MACS) and fluorescent in situ hybridization (FISH) techn

73 lood by magnetically activated cell sorting (MACS) and sheep erythrocyte rosetting methods, and the q

74 (FACS) and magnetic-activated cell sorting (MACS) are underreported.

75 protocol of magnetic-activated cell sorting (MACS) to separate them effectively both as viable and bi

76 nction with magnetic activated cell sorting (MACS), followed with a flow cytometric cell sorting (FAC

77 on, such as magnetic activated cell sorting (MACS), only allow the binary separation of target cells

78 at combines magnetic activated cell sorting (MACS)-based screening of yeast surface display (YSD) lib

79 (EpCAM) via magnetic-activated cell sorting (MACS).

80 (FACS) and magnetic-activated cell sorting (MACS).

81 ll sorting (FACS) and magnetic cell sorting (MACS).

82 ed- and fluorescence activated cell sorting (MACS-FACS) based protocol for CEC isolation.

83 The magic-angle coil spinning (MACS) resonator allows a simple approach for nanoliter n

84 e microchannelled alkylated chitosan sponge (MACS) exhibits the capacity for water and blood absorpti

85 tal Corticosteroids for Preterm Birth Study (MACS) was an international randomized clinical trial tha

86 rg-Munster Affective Disorders Cohort Study (MACS) and completed the Life Events Questionnaire (LEQ)

87 combined the Multicenter AIDS Cohort Study (MACS) and the Women's Interagency HIV Study (WIHS) into

88 (HIV) in the Multicenter AIDS Cohort Study (MACS) and Women's Interagency HIV Study (WIHS) from 1984

89 axis from the Multicenter AIDS Cohort Study (MACS) during 1989-1993.

90 ants from the Multicenter AIDS Cohort Study (MACS) of homosexual and bisexual men enrolled in 1984-19

91 data from the Melbourne Atopy Cohort Study (MACS) participants (n = 936).

92 d HIV) in the Multicenter AIDS Cohort Study (MACS) were stimulated with peptide pools spanning 19 CMV

93 ters from the Multicenter AIDS Cohort Study (MACS) who were selected to reflect the full spectrum of

94 launch of the Multicenter AIDS Cohort Study (MACS), a cohort study of homosexual men in 4 US cities,

95 nually by the Multicenter AIDS Cohort Study (MACS), a four-center prospective cohort study of acquire

96 ut HIV in the Multicenter AIDS Cohort Study (MACS), a longstanding study of the natural and treated h

97 er FOR 2107 Affective Disorder Cohort Study (MACS), collected between September 2014 and November 201

98 ipants in the Multicenter AIDS Cohort Study (MACS), the District of Columbia Gay (DCG) Study, and the

99 ed within the Multicenter AIDS Cohort Study (MACS), using serum samples obtained 2 years prior to dia

100 nfection, the Multicenter AIDS Cohort Study (MACS), was established; 10 years later, the Women's Inte

101 Utilizing the Multicenter AIDS Cohort Study (MACS), we retrospectively examined the early HIV-1-speci

102 o-A-Mano, the Mexican American Cohort Study (MACS).

103 from the UCLA Multicenter AIDS Cohort Study (MACS).

104 o-A-Mano, the Mexican American Cohort Study (MACS).

105 groups in the Multicenter AIDS Cohort Study (MACS).

106 tients in the Multicenter AIDS Cohort Study (MACS).

107 ponent of the Multicenter AIDS Cohort Study (MACS).

108 teer from the Multicenter AIDS Cohort Study (MACS).

109 ples from the Multicenter AIDS Cohort Study (MACS; samples were collected in heparin-containing tubes

110 tivation can lead to MC activation syndrome (MACS), which is observed in patients with long COVID.

111 The MACS cohort continues to be followed actively 3 decades

112 The MACS enrolled participants through a range of community

113 e tested the novel MLP1 polymorphism and the MACS flanking markers in a series of 43 Caucasian simple

114 Demographic differences between the MACS and WIHS can confound analyses by sex.

115 sponge, CELOX(TM), and CELOX(TM)-gauze, the MACS provides higher pro-coagulant and hemostatic capaci

116 say-adjusted HIV-1 RNA concentrations in the MACS and BCDTP.

117 a redshift z = 0.54 elliptical galaxy in the MACS J1149.6+2223 cluster.

118 50% compared with previous donations in the MACS.

119 We compared PWH enrolled in the MACS/WIHS Combined Cohort Study who switched/added an IN

120 % with HIV; 2304 samples) and 990 men in the MACS/WIHS Combined Cohort Study.

121 7) or CH-C (n = 343) at study entry into the MACS were prospectively followed to death, last follow-u

122 omen's Interagency HIV Study (WIHS) into the MACS/WIHS Combined Cohort Study (MWCCS).

123 -handling components and the creation of the MACS microfluidics chip.

124 entrations in archived plasma samples of the MACS was confirmed by the similarity of CD4(+)-cell coun

125 Overall, the MACS demonstrates promising clinical translational poten

126 In contrast to MACS, the MLP and Mlp promoters contain a TATA box appro

127 OVA-sensitized BALB/c mice were sorted using MACS and FACS for phenotype analysis.

128 ently, the spectral resolution acquired with MACS is not efficient for detailed characterization of s

129 renalectomy on comorbidities associated with MACS.

130 Identifying patients with MACS who are most likely to benefit from adrenalectomy i

131 orbidity in some, but not all, patients with MACS.

132 f long-term medical therapy in patients with MACS.

133 escents with CP (N = 14; Age = 15.7 4 years; MACS I-III; GMFCS I-IV) and neurotypical (NT) adolescent